Skip to content

Monthly Archives: September 2013

The Management of Gout (Prophylaxis of Acute Attacks)


This post is based on the 2012 clinical guideline from American College of Rheumatology. The Panel recommended pharmacologic antiinflammatory prophylaxis for all case scenarios of gout where ULT was initiated, given high gout attack rate frequencies in early ULT. Prophylaxis Regimen Oral colchicine is a first-line option. Low-dose NSAIDs is also a first-line choice, however […]

[Update on Sep 23rd 2013] The Management of Gout Part 1 (ULT and CTGA)


In afore blog we had discussed about the management of gout. Today we update the information for the management of gout based on the latest (2012) clinical guidelines for the management of gout from American College of Rheumatology. In this post we will discuss about the urate-lowering therapy (ULT) and chronic gouty arthritis with tophaceous […]

The Management of Multiple Myeloma in Younger Patients


Therapy for multiple myeloma (MM) has advanced with gratifying speed over the past 5 to 7 years and with this progress, a degree of uncertainty has arisen about optimal approaches to therapy, particularly in the newly diagnosed patients. Indeed, using mordern therapeutic strategies, living with MM for a decade or longer has now become a […]

Glycemic Goals in Adult with Diabetes


Generally there are two primary techniques for health providers and patients to evaluate the effectiveness of the management plan on glycemic control: patient self-monitoring of blood glucose or interstitial glucose, and A1C. What should be emphasized is that A1C has a strong predictive value for diabetes complications. Hyperglycemia defines diabetes, and glycemic control is fundamental […]